Does RUXOLITINIB Cause Product availability issue? 2,142 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,142 reports of Product availability issue have been filed in association with RUXOLITINIB (OPZELURA). This represents 3.1% of all adverse event reports for RUXOLITINIB.
2,142
Reports of Product availability issue with RUXOLITINIB
3.1%
of all RUXOLITINIB reports
20
Deaths
188
Hospitalizations
How Dangerous Is Product availability issue From RUXOLITINIB?
Of the 2,142 reports, 20 (0.9%) resulted in death, 188 (8.8%) required hospitalization, and 12 (0.6%) were considered life-threatening.
Is Product availability issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 2,142 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Product availability issue?
LISDEXAMFETAMINE DIMESYLATE (1,530)
CERTOLIZUMAB PEGOL (1,381)
VEDOLIZUMAB (636)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610)
METHYLPHENIDATE (444)
SECUKINUMAB (399)
BIMEKIZUMAB-BKZX (364)
LACOSAMIDE (359)
BRIVARACETAM (324)
SACUBITRIL\VALSARTAN (283)
Which RUXOLITINIB Alternatives Have Lower Product availability issue Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE